New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Aligos Therapeutics, Inc. (ALGS) vs aTyr Pharma, Inc. (ATYR)
- Aligos Therapeutics, Inc. ALGS 1.22 −2.40%
- aTyr Pharma, Inc. ATYR 3.82 +3.52%
Aligos Therapeutics, Inc. and aTyr Pharma, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and aTyr Pharma, Inc. are of similar size ($9.0M and $8.8M). aTyr Pharma, Inc. has the higher net margin (−155.2% vs −197.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, aTyr Pharma, Inc. leads on 9 and Aligos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ALGS | ATYR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (215.55%) | (152.19%) | 0.00% |
| Net margin | (197.01%) | (155.18%) | 0.00% |
| Free cash flow margin | (204.07%) | (148.11%) | 0.00% |
| Return on equity | (159.46%) | (93.69%) | (51.58%) |
| Return on assets | (84.46%) | (64.07%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack